Interferon treatment of hepatitis B-associated membranous glomerulonephritis and nephrotic syndrome
β Scribed by Nisan Gilboa; Deborah Neigut
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 192 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The first case of hepatitis B-associated membranous glomerulonephritis was described by Combes et al. in 1971 (1). Since that time, numerous other cases have been reported and were reviewed recently (2). In many cases, HBsAg or HBeAg has been detected in immune complexes along the glomerular capilla
We have investigated the efficacy of a relatively prolonged course of recombinant leukocyte interferon treatment in 14 chronic HBsAg-, HBeAg-, hepatitis B virus DNA-and DNA polymerasepositive carriers. a-Interferon was administered for 9 weeks. Six of 14 treated carriers have a sustained loss of HBe